Ang II increased the incidence of arrhythmias, especially during ischemia/reperfusion, and blockade of the Ang II type 1 receptor (AT1R) reduced the incidence of arrhythmias as well as mortality after MI [88]. Here, AGTR1 is linked to cardiac arrhythmia.